🇺🇸 FDA
Patent

US 8637079

Solid preparation comprising alogliptin and pioglitazone

granted A61KA61K31/4439A61K31/4545

Quick answer

US patent 8637079 (Solid preparation comprising alogliptin and pioglitazone) held by Takeda Pharmaceutical Company Limited expires Mon Jan 23 2034 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Takeda Pharmaceutical Company Limited
Grant date
Tue Jan 28 2014 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jan 23 2034 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
4
CPC classes
A61K, A61K31/4439, A61K31/4545, A61K9/209, A61P